Chikungunya virus envelope-specific human monoclonal antibodies with broad neutralization potency

Journal of Immunology

Volumn 186, Issue 5, 2011, Pages 3258-3264

  Warter, Lucile ^a   Lee, Chia Yin ^a   Thiagarajan, Rekha ^a   Grandadam, Marc ^b   Lebecque, Serge ^c   Lin, Raymond T P ^d   Bertin Maghit, Sebastien ^a   Ng, Lisa F P ^a   Abastado, Jean Pierre ^a   Desprès, Philippe ^b   Wang, Cheng I ^a   Nardin, Alessandra ^a  

^a AGENCY FOR SCIENCE   (Singapore)

^b INSTITUT PASTEUR   (France)

^c UNIVERSITÉ LYON 1   (France)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN E1; GLYCOPROTEIN E2; HUMAN MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 5F10; MONOCLONAL ANTIBODY 8B10; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ANTIBODY ISOLATION; ANTIVIRAL ACTIVITY; ARTICLE; B LYMPHOCYTE; CHIKUNGUNYA; CHIKUNGUNYA ALPHAVIRUS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CROSS REACTION; DRUG POTENCY; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; SERODIAGNOSIS; VIRUS ATTACHMENT; VIRUS ENVELOPE; VIRUS ISOLATION; VIRUS NEUTRALIZATION; VIRUS PARTICLE; VIRUS RECOMBINANT;

ALPHAVIRUS INFECTIONS; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEUTRALIZING; BINDING SITES, ANTIBODY; CELL LINE, TRANSFORMED; CERCOPITHECUS AETHIOPS; CHIKUNGUNYA VIRUS; HEK293 CELLS; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOGLOBULIN G; NEUTRALIZATION TESTS; RECOMBINANT PROTEINS; VERO CELLS; VIRAL ENVELOPE PROTEINS;

EID: 79952773018     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1003139     Document Type: Article

References (46)

1. Khan, A. H., K. Morita, C. Parquet Md Mdel, F. Hasebe, E. G. Mathenge, and A. Igarashi. 2002. Complete nucleotide sequence of chikungunya virus and evidence for an internal polyadenylation site. J. Gen. Virol. 83: 3075-3084.
2. Strauss, J. H., and E. G. Strauss. 1994. The alphaviruses: gene expression, replication, and evolution. Microbiol. Rev. 58: 491-562.
3. Robinson, M. C. 1955. An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952-53. I. Clinical features. Trans. R. Soc. Trop. Med. Hyg. 49: 28-32.
4. Hammon, W. M., A. Rudnick, and G. E. Sather. 1960. Viruses associated with epidemic hemorrhagic fevers of the Philippines and Thailand. Science 131: 1102-1103.
5. Charrel, R. N., X. de Lamballerie, and D. Raoult. 2007. Chikungunya outbreaks - the globalization of vectorborne diseases. N. Engl. J. Med. 356: 769-771.
6. Rezza, G., L. Nicoletti, R. Angelini, R. Romi, A. C. Finarelli, M. Panning, P. Cordioli, C. Fortuna, S. Boros, F. Magurano, et al; CHIKV study group. 2007. Infection with chikungunya virus in Italy: an outbreak in a temperate region. Lancet 370: 1840-1846.
7. Enserink, M. 2007. Infectious diseases. Chikungunya: no longer a third world disease. Science 318: 1860-1861.
8. Gérardin, P., V. Guernier, J. Perrau, A. Fianu, K. Le Roux, P. Grivard, A. Michault, X. de Lamballerie, A. Flahault, and F. Favier. 2008. Estimating Chikungunya prevalence in La Réunion Island outbreak by serosurveys: two methods for two critical times of the epidemic. BMC Infect. Dis. 8: 99.
9. Staples, J. E., R. F. Breiman, and A. M. Powers. 2009. Chikungunya fever: an epidemiological review of a re-emerging infectious disease. Clin. Infect. Dis. 49: 942-948.
10. Tesh, R. B. 1982. Arthritides caused by mosquito-borne viruses. Annu. Rev. Med. 33: 31-40.
11. Borgherini, G., P. Poubeau, A. Jossaume, A. Gouix, L. Cotte, A. Michault, C. Arvin-Berod, and F. Paganin. 2008. Persistent arthralgia associated with chikungunya virus: a study of 88 adult patients on reunion island. Clin. Infect. Dis. 47: 469-475.
12. Brighton, S.W., O.W. Prozesky, and A. L. de la Harpe. 1983. Chikungunya virus infection. A retrospective study of 107 cases. S. Afr. Med. J. 63: 313-315.
13. Kennedy, A. C., J. Fleming, and L. Solomon. 1980. Chikungunya viral arthropathy: a clinical description. J. Rheumatol. 7: 231-236. (Pubitemid 11222940)
14. Larrieu, S., N. Pouderoux, T. Pistone, L. Filleul, M. C. Receveur, D. Sissoko, K. Ezzedine, and D. Malvy. 2010. Factors associated with persistence of arthralgia among Chikungunya virus-infected travellers: report of 42 French cases. J. Clin. Virol. 47: 85-88.
15. Soumahoro, M. K., P. Gérardin, P. Y. Boëlle, J. Perrau, A. Fianu, J. Pouchot, D. Malvy, A. Flahault, F. Favier, and T. Hanslik. 2009. Impact of Chikungunya virus infection on health status and quality of life: a retrospective cohort study. PLoS ONE 4: e7800.
16. Sissoko, D., D. Malvy, K. Ezzedine, P. Renault, F. Moscetti, M. Ledrans, and V. Pierre. 2009. Post-epidemic Chikungunya disease on Reunion Island: course of rheumatic manifestations and associated factors over a 15-month period. PLoS Negl. Trop. Dis. 3: e389.
17. Bouquillard, E., and B. Combe. 2009. A report of 21 cases of rheumatoid arthritis following Chikungunya fever. A mean follow-up of two years. Joint Bone Spine 76: 654-657.
18. Brighton, S. W., and I. W. Simson. 1984. A destructive arthropathy following Chikungunya virus arthritis - a possible association. Clin. Rheumatol. 3: 253-258.
19. Fourie, E. D., and J. G. Morrison. 1979. Rheumatoid arthritic syndrome after chikungunya fever. S. Afr. Med. J. 56: 130-132.
20. Fritel, X., O. Rollot, P. Gerardin, B. A. Gauzere, J. Bideault, L. Lagarde, B. Dhuime, E. Orvain, F. Cuillier, D. Ramful, et al; Chikungunya-Mere-Enfant Team. 2010. Chikungunya virus infection during pregnancy, Reunion, France, 2006. Emerg. Infect. Dis. 16: 418-425.
21. Gérardin, P., G. Barau, A. Michault, M. Bintner, H. Randrianaivo, G. Choker, Y. Lenglet, Y. Touret, A. Bouveret, P. Grivard, et al. 2008. Multidisciplinary prospective study of mother-to-child chikungunya virus infections on the island of La Réunion. PLoS Med. 5: e60.
22. Ramful, D., M. Carbonnier, M. Pasquet, B. Bouhmani, J. Ghazouani, T. Noormahomed, G. Beullier, T. Attali, S. Samperiz, A. Fourmaintraux, and J. L. Alessandri. 2007. Mother-to-child transmission of Chikungunya virus infection. Pediatr. Infect. Dis. J. 26: 811-815.
23. Michault, A., and F. Staikowsky. 2009. Chikungunya: first steps toward specific treatment and prophylaxis. J. Infect. Dis. 200: 489-491.
24. Akahata, W., Z. Y. Yang, H. Andersen, S. Sun, H. A. Holdaway, W. P. Kong, M. G. Lewis, S. Higgs, M. G. Rossmann, S. Rao, and G. J. Nabel. 2010. A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection. Nat. Med. 16: 334-338.
25. Couderc, T., N. Khandoudi, M. Grandadam, C. Visse, N. Gangneux, S. Bagot, J. F. Prost, and M. Lecuit. 2009. Prophylaxis and therapy for Chikungunya virus infection. J. Infect. Dis. 200: 516-523.
26. Casadevall, A., E. Dadachova, and L. A. Pirofski. 2004. Passive antibody therapy for infectious diseases. Nat. Rev. Microbiol. 2: 695-703.
27. Saylor, C., E. Dadachova, and A. Casadevall. 2009. Monoclonal antibody-based therapies for microbial diseases. Vaccine 27(Suppl. 6): G38-G46.
28. Bréhin, A. C., L. Rubrecht, M. E. Navarro-Sanchez, V. Maréchal, M. P. Frenkiel, P. Lapalud, D. Laune, A. A. Sall, and P. Desprès. 2008. Production and characterization of mouse monoclonal antibodies reactive to Chikungunya envelope E2 glycoprotein. Virology 371: 185-195.
29. Johnson, S., C. Oliver, G. A. Prince, V. G. Hemming, D. S. Pfarr, S. C. Wang, M. Dormitzer, J. O'Grady, S. Koenig, J. K. Tamura, et al. 1997. Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus. J. Infect. Dis. 176: 1215-1224.
30. ter Meulen, J., E. N. van den Brink, L. L. Poon, W. E. Marissen, C. S. Leung, F. Cox, C. Y. Cheung, A. Q. Bakker, J. A. Bogaards, E. van Deventer, et al. 2006. Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants. PLoS Med. 3: e237.
31. Funaro, A., G. Gribaudo, A. Luganini, E. Ortolan, N. Lo Buono, E. Vicenzi, L. Cassetta, S. Landolfo, R. Buick, L. Falciola, et al. 2008. Generation of potent neutralizing human monoclonal antibodies against cytomegalovirus infection from immune B cells. BMC Biotechnol. 8: 85.
32. Throsby, M., E. van den Brink, M. Jongeneelen, L. L. Poon, P. Alard, L. Cornelissen, A. Bakker, F. Cox, E. van Deventer, Y. Guan, et al. 2008. Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells. PLoS ONE 3: e3942.
33. Vogt, M. R., B. Moesker, J. Goudsmit, M. Jongeneelen, S. K. Austin, T. Oliphant, S. Nelson, T. C. Pierson, J. Wilschut, M. Throsby, and M. S. Diamond. 2009. Human monoclonal antibodies against West Nile virus induced by natural infection neutralize at a postattachment step. J. Virol. 83: 6494-6507.
34. Powers, A. M., A. C. Brault, R. B. Tesh, and S. C. Weaver. 2000. Re-emergence of Chikungunya and O'nyong-nyong viruses: evidence for distinct geographical lineages and distant evolutionary relationships. J. Gen. Virol. 81: 471-479.
35. Schuffenecker, I., I. Iteman, A. Michault, S. Murri, L. Frangeul, M. C. Vaney, R. Lavenir, N. Pardigon, J. M. Reynes, F. Pettinelli, et al. 2006. Genome microevolution of chikungunya viruses causing the Indian Ocean outbreak. PLoS Med. 3: e263.
36. Leo, Y. S., A. L. Chow, L. K. Tan, D. C. Lye, L. Lin, and L. C. Ng. 2009. Chikungunya outbreak, Singapore, 2008. Emerg. Infect. Dis. 15: 836-837.
37. Ng, L. C., and H. C. Hapuarachchi. 2010. Tracing the path of Chikungunya virus - evolution and adaptation. Infect. Genet. Evol. 10: 876-885.
38. Levinson, R. S., J. H. Strauss, and E. G. Strauss. 1990. Complete sequence of the genomic RNA of O'nyong-nyong virus and its use in the construction of alphavirus phylogenetic trees. Virology 175: 110-123.
39. Blackburn, N. K., T. G. Besselaar, and G. Gibson. 1995. Antigenic relationship between chikungunya virus strains and o'nyong nyong virus using monoclonal antibodies. Res. Virol. 146: 69-73.
40. Chanas, A. C., Z. Hubalek, B. K. Johnson, and D. I. Simpson. 1979. A comparative study of O'nyong nyong virus with Chikungunya virus and plaque variants. Arch. Virol. 59: 231-238.
41. Chopra, A., V. Anuradha, V. Lagoo-Joshi, V. Kunjir, S. Salvi, and M. Saluja. 2008. Chikungunya virus aches and pains: an emerging challenge. Arthritis Rheum. 58: 2921-2922.
42. Hoarau, J. J., M. C. Jaffar Bandjee, P. Krejbich Trotot, T. Das, G. Li-Pat-Yuen, B. Dassa, M. Denizot, E. Guichard, A. Ribera, T. Henni, et al. 2010. Persistent chronic inflammation and infection by Chikungunya arthritogenic alphavirus in spite of a robust host immune response. J. Immunol. 184: 5914-5927.
43. Kuno, G. 2001. Persistence of arboviruses and antiviral antibodies in vertebrate hosts: its occurrence and impacts. Rev. Med. Virol. 11: 165-190.
44. Maek-A-Nantawat, W., and U. Silachamroon. 2009. Presence of autoimmune antibody in chikungunya infection. Case Report Med 2009: 840183.
45. Schwartz, O., and M. L. Albert. 2010. Biology and pathogenesis of chikungunya virus. Nat. Rev. Microbiol. 8: 491-500.
46. Després, P., J. W. Griffin, and D. E. Griffin. 1995. Antiviral activity of alpha interferon in Sindbis virus-infected cells is restored by anti-E2 monoclonal antibody treatment. J. Virol. 69: 7345-7348.